PepGen

PepGen

  • Founded: 2018
  • Location: Cambridge, MA
  • Employee range: 11 - 50
  • Funding: $108M IPO Oct 2022; $112.5M Aug 2021; $45M A Dec 2020
  • Investors: RA Capital


pepgen.com

linkedin.com

job board


Short description:

Peptide Conjugation Technology for Gene Delivery

Drug notes:

Contact us to add description: recruit@workinbiotech.com

Long description:

PepGen Therapeutics is creating the next generation of oligonucleotide therapies to transform treatments of neuromuscular diseases. Oligonucleotides delivered into cells can modulate RNA expression to treat disease. PepGen is using their proprietary Enhanced Delivery Oligonucleotide (EDO) platform to identify cell-penetrating peptide conjugates that improve the activity and tolerability of oligonucleotide cargo therapeutics. PepGen’s proprietary EDO peptides are engineered for optimal tissue and cell penetration and have been shown to transport oligonucleotides into many target tissues including skeletal and cardiac muscle. PepGen is generating a pipeline of oligonucleotide therapies that target the root cause of serious neuromuscular diseases.

Jobs:

PepGen
Senior Director, Drug Substance
Boston, MA|3 days ago
Apply
PepGen
Scientist, Discovery
Boston, MA|16 days ago
PepGen
Director/Senior Director, Regulatory Strategist – ...
Boston, MA|16 days ago
PepGen
Associate Director, Analytical Development
Boston, MA|26 days ago
PepGen
Senior Specialist, Quality Assurance
Boston, MA|26 days ago
PepGen
Associate Director/Director, Biomarkers
Boston, MA|53 days ago
PepGen
Scientist I/II, Analytical Development
Boston, MA|72 days ago


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com